[HTML][HTML] Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study
Background: Since 2013, Tenofovir (TDF) and Zidovudine (AZT) based regimen are
alternatively used as a first line for treatment of HIV in Tanzania. CD4+ cells count, which is …
alternatively used as a first line for treatment of HIV in Tanzania. CD4+ cells count, which is …
[PDF][PDF] Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study
M Lugoba, M Kilonzi, GM Bwire… - … Med Public Health, 2019 - healthdisgroup.us
Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective
cohort study Page 1 043 Citation: Lugoba M, Kilonzi M, Bwire GM, Ndayishimiye P, Mikomangwa …
cohort study Page 1 043 Citation: Lugoba M, Kilonzi M, Bwire GM, Ndayishimiye P, Mikomangwa …
[PDF][PDF] Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study
M Lugoba, M Kilonzi, GM Bwire… - Arch Community Med …, 2019 - researchgate.net
Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective
cohort study Page 1 043 Citation: Lugoba M, Kilonzi M, Bwire GM, Ndayishimiye P, Mikomangwa …
cohort study Page 1 043 Citation: Lugoba M, Kilonzi M, Bwire GM, Ndayishimiye P, Mikomangwa …
[PDF][PDF] Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective cohort study
M Lugoba, M Kilonzi, GM Bwire… - Arch Community Med …, 2019 - researchgate.net
Immunological outcomes between Tenofovir versus Zidovudine-based regimens: a retrospective
cohort study Page 1 043 Citation: Lugoba M, Kilonzi M, Bwire GM, Ndayishimiye P, Mikomangwa …
cohort study Page 1 043 Citation: Lugoba M, Kilonzi M, Bwire GM, Ndayishimiye P, Mikomangwa …